ALDER BIOPHARMACEUTICALS INC Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALDER BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALDER BIOPHARMACEUTICALS INC for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | Sr. VP & General Co ... | Option Exercise | A | 20.40 | 50,000 | 1,020,000 | 50,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Option Exercise | A | 20.40 | 50,000 | 1,020,000 | 50,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Grant | A | 20.20 | 742 | 14,988 | 30,989 | 30.2 K to 31 K (+2.45 %) |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | SVP, Pharmaceutical ... | Option Exercise | A | 20.40 | 60,000 | 1,224,000 | 60,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Whitaker Timothy M | Chief Medical Offic ... | Option Exercise | A | 20.40 | 75,000 | 1,530,000 | 75,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 20.40 | 95,000 | 1,938,000 | 95,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 20.40 | 75,000 | 1,530,000 | 75,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Sr. VP Translationa ... | Option Exercise | A | 20.40 | 85,000 | 1,734,000 | 85,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | A | 20.40 | 275,000 | 5,610,000 | 275,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Grant | A | 20.20 | 404 | 8,161 | 115,172 | 114.8 K to 115.2 K (+0.35 %) |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | A | 20.40 | 60,000 | 1,224,000 | 60,000 | |
| Jan 20 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 1.65 | 1,498 | 2,472 | 33,039 | |
| Jan 20 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 23.10 | 1,498 | 34,599 | 99,932 | 101.4 K to 99.9 K (-1.48 %) |
| Jan 20 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 1.65 | 1,498 | 2,472 | 101,430 | 99.9 K to 101.4 K (+1.50 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 1.65 | 500 | 825 | 34,537 | |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 1.65 | 1,326 | 2,188 | 35,037 | |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 1.27 | 5,474 | 6,925 | 0 | |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Option Exercise | M | 1.27 | 2,216 | 2,803 | 5,474 | |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 23.00 | 500 | 11,500 | 99,932 | 100.4 K to 99.9 K (-0.50 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | M | 1.65 | 500 | 825 | 100,432 | 100.9 K to 100.4 K (-0.50 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 23.02 | 6,800 | 156,520 | 99,932 | 106.7 K to 99.9 K (-6.37 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 1.65 | 1,326 | 2,188 | 106,732 | 105.4 K to 106.7 K (+1.26 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 1.27 | 5,474 | 6,925 | 105,406 | 99.9 K to 105.4 K (+5.48 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 23.00 | 2,216 | 50,972 | 99,932 | 102.1 K to 99.9 K (-2.17 %) |
| Jan 09 2017 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Buy | M | 1.27 | 2,216 | 2,803 | 102,148 | 99.9 K to 102.1 K (+2.22 %) |